Moderna says its COVID-19 vaccine strongly protects kids as young as 12, a step that could put the shot on track to become the second option for that age group in the US.
With global vaccine supplies still tight, much of the world is struggling to vaccinate adults in the quest to end the pandemic. But earlier this month, the US and Canada authorized another vaccine — the shot made by Pfizer and BioNTech — to be used starting at age 12.
Moderna aims to be next in line, saying it will submit its teen data to the US Food and Drug Administration and other global regulators early next month.
The company studied more than 3,700 12- to 17-year-olds. Preliminary findings show the vaccine triggered the same signs of immune protection in kids as it does in adults, and the same kind of temporary side effects such as sore arms, headache and fatigue.
There were no COVID-19 diagnoses in those given two doses of the Moderna vaccine compared with four cases among kids given dummy shots. In a press release, the company also says the vaccine appeared 93% effective two weeks after the first dose.
While children are far less likely than adults to get seriously ill from COVID-19, they represent about 14% of the nation’s coronavirus cases. At least 316 have died in the US alone, according to a tally by the American Academy of Pediatrics.
Illustrative: A Palestinian medic displays a vial of the Moderna COVID-19 vaccine in the West Bank city of Bethlehem, February 3, 2021, as the Palestinian Authority began administering coronavirus vaccinations after receiving several thousands of doses of the Moderna vaccine from Israel. (AP Photo/Nasser Nasser)
Help us report truthfully on social media
As a multimedia journalist, my job is to take the quality, fact-based journalism produced by The Times of Israel newsroom and make it accessible across every platform — from Instagram posts to podcasts to short-form videos.
This is how many, especially young people, consume news these days. But misinformation is rampant on social media. Our team at ToI produces accurate, responsible short-form reporting on Israel and the Jewish world.
If you believe in the importance of factual social media journalism, please consider joining our reader support group, The Times of Israel Community. Your financial support is essential to sustain responsible multimedia reporting.
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we started the Times of Israel - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Thank you, David Horovitz, Founding Editor of The Times of Israel
From the Liveblog of
Tuesday, May 25, 2021
Add ToI as a Preferred Source on Google
